INS and type 1 diabetes mellitus: Moreover, a multicenter, double-blind, parallel-group trial found that liraglutide treatment leads to significant preservation of residual beta-cell function and reduction in daily insulin requirements during the first year after diagnosis in patients with new-onset T1D [100].